Materials for immunotherapy

CW Shields IV, LLW Wang, MA Evans… - Advanced …, 2020 - Wiley Online Library
Breakthroughs in materials engineering have accelerated the progress of immunotherapy in
preclinical studies. The interplay of chemistry and materials has resulted in improved …

Clinical applications of DNA vaccines: current progress

B Ferraro, MP Morrow, NA Hutnick… - Clinical infectious …, 2011 - academic.oup.com
It was discovered almost 20 years ago that plasmid DNA, when injected into the skin or
muscle of mice, could induce immune responses to encoded antigens. Since that time, there …

DNA vaccines: an historical perspective and view to the future

MA Liu - Immunological reviews, 2011 - Wiley Online Library
This review provides a detailed look at the attributes and immunologic mechanisms of
plasmid DNA vaccines and their utility as laboratory tools as well as potential human …

Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases

A Bolhassani, S Javanzad, T Saleh… - Human vaccines & …, 2014 - Taylor & Francis
Nanocarriers with various compositions and biological properties have been extensively
applied for in vitro/in vivo drug and gene delivery. The family of nanocarriers includes …

Technologies for enhanced efficacy of DNA vaccines

F Saade, N Petrovsky - Expert review of vaccines, 2012 - Taylor & Francis
Despite many years of research, human DNA vaccines have yet to fulfill their early promise.
Over the past 15 years, multiple generations of DNA vaccines have been developed and …

Prevention of cervical cancer through papillomavirus vaccination

IH Frazer - Nature Reviews Immunology, 2004 - nature.com
A subset of human papillomaviruses (HPVs) promote anogenital malignancy, including
cervical cancer, and prevention and treatment strategies that reflect the causal role of HPV …

Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine

MJP Welters, GG Kenter, SJ Piersma, APG Vloon… - Clinical Cancer …, 2008 - AACR
Purpose: The study aims to evaluate the effect of a human papillomavirus type 16 (HPV16)
E6 and E7 synthetic long peptides vaccine on the antigen-specific T-cell response in …

DNA vaccines: precision tools for activating effective immunity against cancer

J Rice, CH Ottensmeier, FK Stevenson - Nature Reviews Cancer, 2008 - nature.com
DNA vaccination has suddenly become a favoured strategy for inducing immunity. The
molecular precision offered by gene-based vaccines, together with the facility to include …

Immunologic treatments for precancerous lesions and uterine cervical cancer

P Vici, L Mariani, L Pizzuti, D Sergi, L Di Lauro… - Journal of Experimental …, 2014 - Springer
Abstract Development of HPV-associated cancers not only depends on efficient negative
regulation of cell cycle control that supports the accumulation of genetic damage, but also …

Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review

EY Chiao, TP Giordano, JM Palefsky… - Clinical Infectious …, 2006 - academic.oup.com
Individuals with human immunodeficiency virus (HIV) infection are at increased risk for
human papillomavirus—related squamous cell cancer of the anus. Screening HIV-infected …